Sign in to view content

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

David S. Boyer, MD

Video
Published 2021

Related

Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 1: Review of the Clarity Study with Dr. Amin Kherani
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Twelve Month Safety and Efficacy Outcomes from a Phase 2 Study of APL-2 in Patients with Geographic Atrophy
David S. Boyer, MD
Updates from the Field
2017

Category: AMD-Non-Neovascular

See more